Loren Data's SAM Daily™

fbodaily.com
Home Today's SAM Search Archives Numbered Notes CBD Archives Subscribe
SAMDAILY.US - ISSUE OF OCTOBER 04, 2024 SAM #8347
SOLICITATION NOTICE

66 -- BD Biosciences BD FACSLyric� 3L10C Lease, Consumables and Service

Notice Date
10/2/2024 8:42:50 AM
 
Notice Type
Presolicitation
 
NAICS
334516 — Analytical Laboratory Instrument Manufacturing
 
Contracting Office
NATIONAL INSTITUTES OF HEALTH - CC BETHESDA MD 20892 USA
 
ZIP Code
20892
 
Solicitation Number
NIH-CC-OPC-25-000002
 
Response Due
10/17/2024 9:00:00 AM
 
Archive Date
11/01/2024
 
Point of Contact
Kimala Winfield, Phone: 3014967015, Malinda Dehner, Phone: 3015946320
 
E-Mail Address
kimala.winfield@nih.gov, dehnerm@cc.nih.gov
(kimala.winfield@nih.gov, dehnerm@cc.nih.gov)
 
Description
This is a Notice of Intent, not a request for a quotation. A solicitation document will not be issued and quotations will not be requested. The National Institute of Health, Clinical Center (CC) intends to award an Indefinite Delivery/Indefinite Quantity (IDIQ) contract to The BD Biosciences, San Diego, CA 92121 on a sole source basis for the lease option to buy BD FACSLyric� 3L10C system instrumentation package inclusive of the supply of proprietary reagents, consumables, tests, and preventative and corrective maintenance service. The comprehensive system of the instrument, reagents, and service are necessary to produce complete testing results and are not sold in the U.S. by any distributors or other third parties, without the �PROPRIETARY� reagents patients in the Clinical Center cannot receive the cell therapy necessary for their treatment per protocols at NIH. Since the supplies are proprietary, there is only one supplier whose products can fit into the instrumentation; any other supply or service could cause the cancellation of the protocol/delays in completion of the protocol. Any deviation from the protocol must be reported to the Food and Drug Administration (FDA) for non-compliance. The Department of Laboratory Medicine (DLM) will telephone or e-mail request for reagents and supplies on a needed basis. The Period of Performance shall be for a base year of twelve (12) months from date of award with four (4) one (1) year option periods. The equipment and supply lists including quantities are attached to this notice and titled: Attachment 1 - List of Equipment and Attachment 2 - List of Supplies. The exact quantity of supplies cannot be estimated at the time of award, therefore an IDIQ contract type is most advantageous for this requirement. This acquisition is being conducted using policies unique to the Federal Acquisition Regulation 13.501 Special documentation requirements for sole source acquisitions exceeding the Simplified Acquisition Threshold. Contracts awarded using FAR Part 13-Simplified Acquisition Procedures are exempt from the requirements of FAR Part 6-Competition Requirements. The North American Industry Classification System (NAICS) code for this acquisition is 334516-Analytical Laboratory Instrument Manufacturing6 with a large small business standard size of 1,000 employees. Interested concerns capable of providing the same or similar products or services as described in this notice may submit a capability statement outlining their capabilities. **** Capability Statements must be received within the time set forth in this synopsis to be considered by the Government. A determination to compete this proposed contract based on responses to this notice is solely within the discretion of the Government. Information received will normally be considered solely for the purpose of determining whether to conduct a competitive procurement. **** Each response should include the following Business Information: a. SAM UIE. b. Company Name, address, POC, Phone and Email address c. Current GSA Schedules or NAICS codes appropriate to this Award. d. Socioeconomic Status: (i.e., small business, 8(a), woman owned, hubZone, veteran owned, etc.) as validated in System for Award Management (SAM). All offerors must register on the SAM located at http://www.sam.gov/portal/SAM/#1 e. Capability Statement Comments to this announcement should be submitted to the Clinical Center, Office of Purchasing and Contracts, prior to the closing date specified in this announcement, electronically to the attention of Kimala Winfield, kimala.winfield@nih.gov or Malinda Dehner, dehnerm@cc.nih.gov by the due date and time marked in this notice.
 
Web Link
SAM.gov Permalink
(https://sam.gov/opp/dcb80d845b1848f3918409d7ec784e8c/view)
 
Place of Performance
Address: Bethesda, MD 20892, USA
Zip Code: 20892
Country: USA
 
Record
SN07231743-F 20241004/241003232214 (samdaily.us)
 
Source
SAM.gov Link to This Notice
(may not be valid after Archive Date)

FSG Index  |  This Issue's Index  |  Today's SAM Daily Index Page |
ECGrid: EDI VAN Interconnect ECGridOS: EDI Web Services Interconnect API Government Data Publications CBDDisk Subscribers
 Privacy Policy  Jenny in Wanderland!  © 1994-2024, Loren Data Corp.